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POLIMORFISME ACE AND ACTN3, KAPASITI AEROBIK DAN 
ANAEROBIK, TULANG DAN PRESTASI OTOT DALAM KALANGAN 
ATLET DAN BUKAN ATLET MELAYU 
 
ABSTRAK 
 
Kajian ini bertujuan untuk menyiasat hubungan antara polimorfisme gen ACE I/D 
dan polimorfisme gen ACTN3 R577X, kapasiti aerobik dan anaerobik, tulang dan 
prestasi otot dalam kalangan atlet dan bukan atlet Melayu. Seramai 132 peserta telah 
menyertai kajian ini. Kesemua peserta atlet (atlet lelaki, n = 33; atlet wanita, n = 33) 
dan bukan atlet (lelaki bukan atlet, n = 33; perempuan bukan atlet, n = 33) Melayu 
telah dikenalpasti genotip polimorfisme ACE gen I/D dan polimorfisme ACTN3 gen 
R577X mereka dengan menggunakan teknik PCR. Nisbah ekspiratori paksa “(FER)”, 
pengambilan oksigen maksima (VO2max) dan kuasa anaerobik ‘Wingate’ dan indeks 
keletihan peserta telah diukur. Sementara itu, pengukuran kuantitatif ultrabunyi iaitu 
kelajuan bunyi terhadap tulang “(SOS)” dan skor-T bagi kaki dan tangan dominan 
dan bukan dominan kesemua peserta telah diukur dengan menggunakan mesin 
sonometer tulang. Kebolehlenturan, kekuatan genggaman tangan, kekuatan kaki dan 
belakang badan, serta kuasa eksplosif lompatan kaki peserta juga telah diukur. Tork 
puncak otot (PT, penunjuk kekuatan otot), tork puncak per berat badan (PT/BW), dan 
purata kuasa (AVG.P) otot lutut dan bahu dominan dan bukan dominan dalam 
keadaan ekstensi dan fleksi pada 60
0
.s
-1
, 180
0
.s
-1 
serta 300
0
.s
-1 
peserta diukur dengan 
menggunakan mesin dinamometer isokinetik BIODEX. Kajian ini menunjukkan 
genotip ACE II berkait dengan VO2max yang lebih tinggi dalam kalangan atlet wanita 
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dan lelaki, dan juga berkait dengan PT otot yang lebih tinggi dalam kalangan atlet 
wanita. Sementara itu, genotip ACE ID berkait dengan kuasa eksplosif lompatan kaki 
yang lebih tinggi dan indeks keletihan yang lebih rendah dalam kalangan atlet wanita, 
dan juga berkait dengan PT otot iaitu kekuatan dan kuasa yang lebih tinggi dalam 
kalangan atlet lelaki. Dalam kalangan wanita bukan atlet, genotip DD berkait dengan 
status kesihatan tulang yang lebih baik. Kajian ini juga mendapati bahawa atlet 
wanita bergenotip ACTN3 RR dan RX berkait dengan kebolehlenturan yang lebih 
tinggi. Sementara itu, atlet wanita yang bergenotip RR berkait dengan kuasa 
eksplosif lompatan kaki yang lebih tinggi. Dalam kalangan atlet lelaki, genotip RR 
berkait dengan purata kuasa yang lebih tinggi. Atlet lelaki dan wanita yang 
bergenotip RR berkait dengan PT otot dan AVG.P, iaitu kekuatan dan kuasa otot yang 
lebih tinggi. Wanita bukan atlet yang bergenotip RR pula berkait dengan status 
kesihatan tulang yang lebih baik. Secara kesimpulan, penemuan semasa yang 
didapati dari kajian ini boleh digunakan sebagai panduan kepada badan-badan sukan 
dan jurulatih dalam pengenalpastian dan pemilihan atlet elit di Malaysia, khususnya 
kumpulan etnik Melayu. 
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ACE AND ACTN3 POLYMORPHISMS, AEROBIC AND ANAEROBIC 
CAPACITIES, BONE AND MUSCULAR PERFORMANCE  
IN MALAY ATHLETES AND NON-ATHLETES 
 
ABSTRACT 
 
This study investigated the association between ACE gene I/D polymorphism and 
ACTN3 gene R577X polymorphism, aerobic and anaerobic capacities, bone and 
muscular performance in Malay athletes and non-athletes. A total of 132 participants 
were recruited in this study. Malay athletes (male athletes, n=33; female athletes, 
n=33) and non-athletes (male non-athletes, n=33; female non-athletes, n=33) 
participants were genotyped for ACE gene I/D polymorphism and ACTN3 gene 
R577X polymorphism by using PCR technique. Forced expiratory ratio (FER), 
maximal oxygen uptake (VO2max) and Wingate anaerobic power were measured. 
Meanwhile, the quantitative ultrasound measurements of bone speed of sound (SOS) 
and T-score of the participants’ dominant and non-dominant legs and arms were 
measured using a bone sonometer. Participants’ flexibility, handgrip strength, back 
and leg strength, leg explosive jump power were also measured. Muscular peak 
torque (PT, an indicator of muscular strength), peak torque per body weight (PT/BW) 
and average power (AVG.P) of the participants’ dominant and non-dominant knee 
and shoulder extension and flexion at 60
0
.s
-1
, 180
0
.s
-1
 and 300
0
.s
-1
 were measured 
using BIODEX isokinetic dynamometer. The present study found that ACE II 
genotype was associated with higher VO2max in female and male athletes, and was 
associated higher muscular PT in female athletes. Meanwhile, ID genotype was 
associated with higher leg explosive jump power and lower fatigue index in female 
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athletes, and was associated with higher muscular PT i.e. strength and power in male 
athletes. In female non-athletes, DD genotype was associated with better bone health 
status. This study also found that ACTN3 RR and RX genotypes were associated with 
higher flexibility in female athletes. Meanwhile, RR genotype was associated with 
leg explosive jump power in female athletes. In male athletes, RR genotype was 
associated with higher mean power. In both female and male athletes, RR genotype 
was associated with higher muscular PT and AVG.P, i.e. muscular strength and power. 
In female non-athletes, RR genotype was associated with better bone health status. In 
conclusion, the present findings obtained from this study can be used to guide the 
decisions of sports bodies and coaches in talent identification and selection of elite 
athletes in Malaysia, especially Malay ethnic group. 
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CHAPTER 1 
INTRODUCTION 
 
 
 
 
 
 
 
1.1 Study background 
 
Efficient human movement is influenced by environmental and behavioral 
factors including training, diet and genetic endowment, and it is believed that genetic 
endowment is one of the factors that can increase the possibility of an individual to 
become an elite athlete (Paparini et al., 2007). Lucia et al. (2010) also mentioned that 
athletic champion status is a complex polygenic trait in which numerous candidate 
genes, complex gene-gene interactions and environment-gene interactions are 
involved.  
 
Genetic factors determine 20-80% of the variations in a wide variety of traits 
that is relevant to athletic performances, such as oxygen uptake, cardiac output and 
relative proportion of fast and slow fibers in skeletal muscle (MacArthur and North 
2007). Several previous studies have identified a large number of individual genes 
underlying the influence of these traits towards athletic performance, and it was 
found that more than 200 genes and quantitative trait loci have been associated with 
athletic performance and physical fitness traits (Ginevičienė et al., 2011a; Ahmetov 
et al., 2009).  
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The talent of a sports person can be defined by the complement of genes that he 
or she inherited from his both parents. Over the course of evolution, families pass on 
their genetic coding from one generation to the next and over time certain 
characteristics of genes are added, subtracted and altered (Schoenfelder, 2010). The 
development of technology for rapid deoxyribonucleic acid (DNA) sequencing and 
genotyping has allowed the identification of some of the individual genetic variations 
that contribute to athletic performance (Patel and Greydanus, 2002). The process of 
talent identiﬁcation by the sports associations and coaches can be revolutionized by 
the discovery and characterization of genetic variants that strongly inﬂuence athletic 
performance, with genetic analysis being added to the existing battery of 
physiological, biochemical and psychological tests that form the current basis for 
selecting talented athletes for further training (Patel and Greydanus, 2002). 
 
Genetic predisposition has great implications in the characterization of an 
individual as a great athlete despite the specific training and nutritional follow-up 
factors. Studies of genes that influence human physical performance show a strong 
heritability of key endurance and strength phenotypes. Endurance phenotype 
includes maximal oxygen uptake while strength phenotype include muscular strength 
(Ginevičienė et al., 2011a; Ahmetov et al., 2009). 
 
One popular gene that has been associated with the tendency of individual 
towards sports is Angiotension I-Convertion Enzyme (ACE) gene. ACE is encoded 
by the ACE gene located on chromosome 17 at position q23.3. The size of the gene is 
44,778 bases, with 21 kb contains 26 exons and 25 introns. There are two forms of 
ACE in human, the production of which depends on whether it is encoded by 
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somatic ACE (sACE) or germinal or testicular ACE (gACE) (Riordan, 2003; Brown 
et al., 2006). Somatic ACE is the longer form of ACE in human which is transcribed 
from exons 1-12 and 14-26, while germinal ACE (shorter form) is transcribed from 
exons 13-26 (Tsianos et al., 2004; Eynon et al., 2009a). The D allele has been shown 
to be associated with increased sprinter performance and muscle powers based on a 
research conducted by Woods et al. (2000) on short distance swimmers. This allele 
was also found to be related to an increase in the strength of the quadricipital thigh 
muscle in response to nine-week isometric strength training (Folland et al., 2000; 
Cięszczyk et al., 2011). Amir et al. (2007) found the overrepresentation of the ACE 
gene D allele and DD genotype among elite Israeli marathon athletes. Similar finding 
was also reported by Tobina et al. (2010). They noted that the DD genotype was 
significantly higher than the II genotype amongst the Japanese athletes, and the 
average running speed was significantly higher for athletes with the combined DD 
and ID genotypes than those with the combined II genotype.  
 
Another popular candidate gene that has shown association with athlete 
performance is α-actinin-3 (ACTN3) gene due to the replacement of arginine (R) to 
stop codon Ter (X), at position 577 of amino acid (MacArthur and North, 2007). It 
results in the deficiency of α-actinin-3 protein. The presence of α-actinin-3 is 
required for optimal fast fiber performance in power athletes (MacArthur and North, 
2007) which majority of the power athletes has the RR and RX genotypes. The 
absence of α-actinin-3 provides some advantage to endurance athlete where the 
majority of the athletes has the XX genotype. 
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It is very intricate and complex to become an elite athlete. Many gene variants 
that influence physical performance in one population might not have the same effect 
in another. The genotype and phenotypic variance exists in different ethnicities and 
populations (Peng et al., 2008). For example, discernable deviations can be observed 
in the genetic profiles of individuals within a less genetically heterogeneous ancestry, 
e.g., among Europeans and Han Chinese (Zilberman-Schapira et al., 2012). Most 
countries are mixture of different races, caused by history of migration centuries ago. 
Any genetic analysis with different ethnic groups might lead to misleading results.  
 
1.2 Research gap of the study 
 
Based on prior studies on association between human sports performance and 
these two genes, to our knowledge, to date there are limited studies focusing on the 
athletic performance and genetic factors among Malay population. Additionally, 
limited study has been performed to investigate ACE I/D and ACTN3 R577X 
polymorphisms in Malay male and female athletes in Malaysia, and limited study has 
investigated the association between the ACE I/D genotypes, ACTN3 R577X 
genotypes, muscular strength and explosive power, aerobic and anaerobic capacities, 
bone and the other sports ability related parameters in this population. Hence, the 
present study was designed to address the paucity of this information. The present 
study aimed to examine the association between ACE I/D and ACTN3 R577X 
polymorphisms, aerobic- and anaerobic-orientated phenotypes, bone health status 
and muscular strength and power among Malay male and female athletes and 
non-athletes.  
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1.3 Research questions 
 
1) What are the genetic similarities (relatedness) between Malay athletes and 
Malay non-athletes in Malaysia? 
 
2) Is there any association between ACE and ACTN3 polymorphisms, aerobic 
capacitiy, i.e. VO2max, Wingate anaerobic capacity, i.e. anaerobic power, bone health 
status, i.e. bone speed of sound, and muscular performance, i.e. isokinetic muscular 
strength and power in Malay male and female athletes and non-athletes? 
 
3) Are ACE gene I/D and ACTN3 gene R577X polymorphisms important in 
determining an individual athletic potential in Malaysia, especially in Malay 
population? 
 
1.4 Objectives of the study 
 
1.4.1 General objective: 
 
To examine the association of ACE gene and ACTN3 gene polymorphisms with 
aerobic and anaerobic capacities, bone, muscular performance and other sports 
ability related parameters in Malay male and female athletes and non-athletes in 
Malaysia. 
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1.4.2 Specific objectives: 
 
1) To examine the presence and frequency distributions of ACE gene I/D 
polymorphism and ACTN3 gene R577X polymorphism in Malay male and female 
athletes and non-athletes. 
 
2) To examine the association between ACE gene I/D polymorphism and 
ACTN3 gene R577X polymorphism with physical and physiological characteristics 
i.e. percent body fat, resting heart rate and blood pressure, aerobic capacity i.e. 
maximal oxygen uptake (VO2max) and forced expiratory ratio (FER), anaerobic 
capacities i.e. mean power, peak power, anaerobic capacity, anaerobic power and 
fatigue index (FI) in Malay male and female athletes and Malay male and female 
non-athletes. 
  
3) To examine the association between ACE gene I/D polymorphism and 
ACTN3 gene R577X polymorphism with quantitative ultrasound measurements of 
bone speed of sound i.e. SOS and also T-score in Malay male and female athletes and 
Malay male and female non-athletes.  
 
4) To examine the association between ACE gene I/D polymorphism and 
ACTN3 gene R577X polymorphism with flexibility, hand grip strength, back and leg 
strength and leg explosive power in Malay male and female athletes and Malay male 
and female non-athletes.  
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5) To examine the association between ACE gene I/D polymorphism and 
ACTN3 gene R577X polymorphism with muscular strength and power measured 
using isokinetic dynamometer, i.e. peak torque, peak torque per body weight and 
average power in Malay male and female athletes and Malay male and female 
non-athletes. 
 
6) To examine the correlation between quantitative ultrasound measurement of 
the bone of lower limbs, muscular performance and anaerobic capacities in Malay 
athletes and Malay male and female non-athletes. 
 
1.5 Hypotheses of the study 
 
HA1: There are associations between ACE gene I/D polymorphism and ACTN3 
gene R577X polymorphism with physical and physiological characteristics i.e. 
percent body fat, resting heart rate, blood pressure, aerobic capacity i.e. maximal 
oxygen uptake (VO2max) and forced expiratory ratio (FER), anaerobic capacities i.e. 
mean power, peak power, anaerobic capacity, anaerobic power and fatigue index (FI) 
in Malay male and female athletes and Malay male and female non-athletes. 
 
HA2: There are associations between ACE gene I/D polymorphism and ACTN3 
gene R577X polymorphism with quantitative ultrasound measurements of bone 
speed of sound i.e. SOS and also T-score in Malay male and female athletes and 
Malay male and female non-athletes. 
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HA3: There are associations between ACE gene I/D polymorphism and ACTN3 
gene R577X polymorphism with flexibility, hands grip strength, back and leg 
strength, leg explosive power in Malay male and female athletes and Malay male and 
female non-athletes. 
 
HA4: There are associations between ACE gene I/D polymorphism and ACTN3 
gene R577X polymorphism with muscular strength and power i.e. peak torque, peak 
torque per body weight and average power in Malay male and female athletes and 
Malay male and female non-athletes. 
 
HA5: There are correlations between quantitative ultrasound measurement of the 
bone of lower limbs, muscular performance and anaerobic capacities in Malay 
athletes and Malay male and female non-athletes. 
 
1.6 Significance of the study 
 
If the present study can find that there are association of ACE gene I/D 
polymorphism and ACTN3 gene R577X polymorphism with aerobic and anaerobic 
capacities, bone, muscular performance and other parameters related to sports ability 
in Malay male and female athletes and non-athletes, the results of the present study 
can then be used in talent identification of elite athletes and champions athletes in 
Malaysia. At the same time the efficiency of elite athlete selection can be improved 
manpower and material resources can also be saved. It is also hoped that results 
obtained from this study can guide the decisions of sports bodies, coaches and 
athletes in the formulation of talent identification that can benefit Malaysian athletes.  
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CHAPTER 2 
LITERATURE REVIEW 
 
 
 
 
 
 
 
 
2.1 Sports disciplines  
 
The two major sports disciplines, i.e. endurance and sprint or power 
performance involve different types of muscle metabolism. Endurance sports require 
high level of aerobic or cardiorespiratory fitness which is represented by maximal 
oxygen uptake (VO2max) of an individual (Plowman and Smith, 2013). Endurance 
discipline depends on aerobic energy metabolism, and the examples are long distance 
swimming, triathlon, skiing, medium and long distance running, race walking, 
mountaineering and cycling. Meanwhile, sprint or power discipline requires 
predominantly anaerobic energy metabolism (Brown et al., 2006) or 
power-generating muscle metabolism (Plowman and Smith, 2013). Examples of 
sprint or power discipline are short distance running, weightlifting and track and 
field events such as high jump and long jump. Besides the two major sports 
disciplines, the third sports discipline is the endurance-speed-strength discipline 
where athletes are involved with an intermediate character of energy metabolism. 
Examples of endurance-speed-strength discipline are hockey, tennis, football, 
volleyball, basketball, handball, rugby and boxing. 
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2.2 Aerobic capacity 
 
Cardio-respiratory fitness includes the function of both the heart and the lungs, 
it reflects the efficiency of the circulatory system to deliver oxygen that is taken into 
the blood through the lungs and the heart to circulate the blood through the arteries 
and veins (Bouchard et al., 1999). Cardio-respiratory of individual indicates how fit 
an individual is aerobically. The maximal ability of an individual to consume oxygen 
is dependent on his/her cardiorespiratory function and the capacity of skeletal muscle 
mitochondria to consume oxygen. Maximal oxygen consumption (VO2max) is one of 
the important predictors of cardiorespiratory fitness, and it is used for assessing one’s 
aerobic capacity (Bassett and Howley, 2000). It is also an indicator of the 
cardiovascular system to deliver oxygenated blood to working muscles and 
utilization of oxygen by the muscles during exercise (Heyward, 2014). Treadmill 
running VO2max test is a common test used for direct assessing VO2max of an 
individual (Joyner and Coyle, 2008), which is accepted as a standard 
cardio-respiratory fitness measurement. While running on treadmill with increasing 
the speed and grade of treadmill gradually, participant’s oxygen and carbon dioxide 
concentrations are assessed by metabolic cart, and the volume of expired air is also 
recorded. VO2max is the volume of oxygen consumption at the exhausting level of 
running during approximately 10-15 minutes (Bouchard et al., 1999; Heyward and 
Gibson, 2014).  
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2.3 Anaerobic capacity 
 
Anaerobic activity is defined as activity involving energy expenditure that uses 
anaerobic metabolism, i.e. without the usage of oxygen, lasting less than 90 seconds 
and utilising an exhaustive effort (Heyward and Gibson, 2014). Wingate anaerobic 
test is the most common test which can assess the anaerobic fitness of an individual. 
Two major energy sources are required during the Wingate anaerobic test 
(MacDougall and Wenger, 1991). The first energy source is the adenosine 
triphosphate-phosphocreatine (ATP-PCr) system, which lasts for 3 to 15 seconds 
during maximum effort. The second system is anaerobic glycolysis, which can be 
sustained for the remainder of the all-out effort. Therefore, the Wingate anaerobic 
test can measure muscles' ability to work using both the ATP-PCr and glycolytic 
systems. Sports persons involving in sports events such as football, sprinting, soccer, 
baseball and gymnastics require anaerobic metabolism during competition. The 
Wingate anaerobic test was designed to measure an individual’s peak power, mean 
power and percent fatigue (Inbar et al., 1996). Besides Wingate anaerobic test, the 
tests which can assess an individual’s power and/or anaerobic capacity are vertical 
jump test and standing long jump test (Bar-Or, 1987).  
 
2.4 Bone health  
 
Bone health is influenced by age, gender, race, nutrition, life style, exercise, and 
hormonal factors as well as muscle strength (Hochberg, 2007; Blain et al., 2001; 
Taaffe et al., 2001; Burr, 1997). Regarding association between muscular strength 
and bone health, Ahedi et al., (2014) investigated the relationship between muscle 
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strength and bone mineral density (BMD) of the hip and spine in 321 Tasmanian 
older adults and reported that hip BMD was positively related to the muscular 
strength, and the authors concluded that higher muscular strength may maintain bone 
health and prevent bone fragility and fractures (Ahedi et al., 2014). Similarly, Lee et 
al. (2014) also reported that muscular strength is associated with BMD of hip in 
healthy elderly women. Regarding the associations between bone mineral density 
and muscle anaerobic capacities, such as explosive power, Nasri et al. (2013) found 
that hand grip strength and explosive leg power were significantly correlated with 
BMD of both spine and legs among fifty adolescent combat sports athletes aged 17 
years.  
 
It is well known that osteoporosis is a systematic bone disease characterized by 
loss of bone contents and progressive deterioration of microarchitecture of the bone, 
which would lead to bone fragility and fractures eventually (Wass and Owen, 2014; 
Tung and Iqbal, 2007). In 1994, the World Health Organization recommended that 
dual energy X-ray absorptiometry (DXA) is the gold standard method for the 
diagnosis of osteoporosis and measurement of bone mineral density (BMD) (W.H.O., 
1994). Nevertheless, many other techniques are available to evaluate bone health in 
recent years (W.H.O., 2004). One of the popular techniques is quantitative ultrasound 
(QUS), which uses sound waves to diagnose osteoporosis and assess bone health of 
an individual (Miura et al., 2008; Mészáros et al., 2007; Baroncelli, 2008; Mimura et 
al., 2008). Today, more and more researchers use devices based on quantitative 
ultrasound to evaluate osteoporosis due to its portability, proper practicality and 
cheaper cost for the public to access. Ng and Sundram (1998) reported that 
quantitative ultrasound provides bone speed of sound (SOS) results which can 
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contribute additional information on bone contents and microarchitectures as well as 
BMD. The speed of sound of bone, which is an alternative to DXA for osteoporosis 
screening, can be measured by quantitative ultrasound through bone at the phalanx, 
radius, tibia and metatarsal (Njeh et al., 2001; Giangregorio and Webber, 2004).  
 
2.5 Muscular strength and power  
 
Muscular strength and power not only impacts the quality of personal daily life, 
but also can reflect a person's sports ability. Muscular strength is the maximal force 
that a muscle can exert. Human skeletal muscle consists of slow-twitch (ST) and 
fast-twitch (FT) which is determined by different protein types or myosin isoform to 
control the speed of contraction of muscle cells. ST cells can elevate blood supply 
and aerobic enzyme content in order to create higher muscular aerobic capacity and 
power, and FT cells have greater muscular anaerobic capacity and power through 
storing higher concentration of glycogen and anaerobic enzymes (Heyward and 
Gibson, 2014). In sports science fields, one of the most common methods to test 
muscular strength and power is manual muscle testing, i.e. hand grip strength testing, 
back and leg strength testing, standing long jump and vertical jump testing. Although 
those manual muscular strength and power testing are less objective when an 
individual has ability to generate high force, these testings are easier and straighter to 
use and assess an individual’s strength and power (Keasays et al., 2000).  
 
Another measurement of muscular strength and power usually examines the 
isometric strength and power, i.e. the maximal force exerted when the limb is not 
moving. Muscular strength and power is the product of force and velocity. By 
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definition, therefore, strength and power can be measured only when the limb is in 
motion. BIODEX isokinetic dynamometer can be used to measure subjects' muscular 
strength and power. Perhaps the most important reason for isokinetic testing is that it 
provides an effective way to attain objective measures. It is demonstrated that this 
instrument provided mechanically valid, reliable and reproducible measures of 
strength and power. Many studies have been performed to document this validity and 
reliability, but there is controversy about which is the most clinically significant 
testing speed. A specific muscular power and strength measured by BIODEX 
isokinetic dynamometer can be assessed as peak torque, peak torque per body weight 
and average power etc.. Peak torque is highest muscular force output, which is 
similar to a one repetition maximum effort in isotonics, and average power is the 
mean value of how effectively the muscle can perform work over time (Plowman and 
Smith, 2013). Isokinetic muscular extension and flexion power and strength were 
normally assessed at 3 angular velocities of movement (with a rest period of 10 
seconds between the trials): 60
0
.s
-1
, 180
0
.s
-1
and 300
0
.s
-1
 (Pincivero et al., 1997). 
Slowest speed tests are generally conducted with 5 repetitions i.e. 60
0
.s
-1
, and faster 
speed tests are usually performed at 10 to 15 repetitions, i.e. 180
0
.s
-1
and 300
0
.s
-1
 
respectively. Testing at each velocity should be consisted of 5 sub-maximal followed 
by 2-3 maximal repetitions for warm-up purposes. During the testing procedure, each 
participant was given verbal encouragement as well as visual feedback from an 
investigator in an attempt to achieve a maximal effort level (Hald and Bottjen, 1987).  
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2.6 Angiotensin converting enzyme gene ID polymorphism and human physical 
performance in different populations and races 
 
Physical fitness is a complex phenotype influenced by environmental and 
genetic factors. Meanwhile variations in human physical performance and athlete 
ability have been recognized as a strong heritable component. The talent of a sports 
person can be defined by the complement of genes that he/she inherited from his/her 
both parents. Over the course of evolution, families pass on their genetic coding from 
one generation to the next and certain characteristics of genes are added, subtracted 
and altered over time. It was estimated that the heritability of athlete status is at 
approximately 66% in a twin pair study by Schoenfelder (2010), but the author did 
not report whether it was influenced by single or multiple genes. In the last two 
decades, many sports science studies have been conducted to investigate the 
relationship of genetics and elite athletic performance, and the association of genetic 
characteristics and their impact on training and exercise. It was expected that, with 
the rapid development of gene-based technologies, more and more researches will be 
carried out in the future to identify genetic predispositions as a contributing factor to 
athletic abilities and performance (Patel and Greydanus, 2002). 
 
Angiotensin converting enzyme (ACE) is a component of circulating 
renin-angiotensin system (RAS) which influences circulatory homeostasis through 
the degradation of vasodilator kinins and generation of vasopressor angiotensin II 
(Ang II). Genetic polymorphisms within the ACE gene could be associated with 
various phenotypic characteristics such as diseases and human performances. To date, 
one of the most popular genetic polymorphisms that has been shown to be associated 
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with athlete performance is ACE gene, which contains a restriction fragment length 
polymorphism consisting of the insertion, I (presence of Alu repeat) and deletion, D 
(absence of Alu repeat) of 287 bp of Alu repeat located in intron 16 (Tsianos et al., 
2004; Maffulli et al., 2013; Guth and Roth, 2013). Previous studies investigating the 
influence of the polymorphism and various phenotypic characteristics have produced 
inconsistent findings due to the inter-ethnic variations of the ACE allele distribution. 
For example, some previous studies showed that I allele was associated with fatigue 
resistance in skeletal muscle and endurance performance, while the D allele has been 
associated with power or sprint performances. Nevertheless, controversy still exists 
in the above conclusion, in which some studies have reported that I allele was 
associated with a better power or sprint performance rather than with endurance 
athletic abilities. This section discusses the ethnic variations of ACE allele 
distribution in different populations and races, including African, American, 
European, Asian populations etc.. Additionally, association between ACE ID 
polymorphism and human fitness among various populations and races were 
discussed. 
 
2.6.1 Renin-angiotensin system (RAS) 
 
According to Basso and Terragno (2001), Tigerstedt and Bergman discovered 
the rate-limiting enzyme renin, and reported the effect of renal extracts about one 
hundred years ago. Then the renin-angiotensin system (RAS) continues to be an 
estimable subject for subsequent research. It is well known that the endocrine 
renin-angiotensin system (RAS) is a key regulator of circulatory homeostasis. In 
other words, it is important for regulating blood pressure and fluid homeostasis 
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(Wang et al., 2008; Puthucheary et al., 2011a; Paul et al., 2006). Renin is a 37 kDa 
aspartyl protease that converts angiotensinogen to decapeptide angiotensin I (Ang I). 
Ang I is in turn acted upon by the peptidyl dipeptidase ACE to generate octapeptide 
angiotensin II (Ang II).   
 
Agonist action of Ang II on angiotensin type-1 receptor (AT1R) causes 
vasoconstriction in arterial blood pressure. Ang II also affects renal sodium 
reabsorption and adrenal aldosterone production, leading to salt and water retention, 
which further influences blood volume and pressure (Wang et al., 2008; Myerson et 
al., 1999). Previous studies have shown that the vasoconstrictor peptide angiotensin 
II also plays an important role in vascular smooth muscle growth (Geisterfer et al., 
1988; Naftilan, 1992).   
 
2.6.2 Angiotensin converting enzyme (ACE) 
 
Angiotensin converting enzyme (ACE) is a component of circulating 
renin-angiotensin system (RAS) which influences circulatory homeostasis through 
the degradation of vasodilator kinins and generation of vasopressor angiotensin II 
(Ang II). ACE is a monomeric, membrane bound, zinc and chloride dependent 
peptidyl dipeptidase that catalyzes the conversion of decapeptide angiotensin I to 
octapeptide angiotensin II, by removing carboxy terminal dipeptide (Brown et al., 
2006).  
 
ACE is encoded by the ACE gene located on chromosome 17 at position q23.3. 
The size of the gene is 44,778 bases, with 21 kb contains 26 exons and 25 introns. 
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There are two forms of ACE in human, the production of which depends on whether 
it is encoded by somatic ACE (sACE) or germinal or testicular ACE (gACE) 
(Riordan, 2003). Somatic ACE is the longer form of ACE in human which is 
transcribed from exons 1-12 and 14-26, while germinal ACE (shorter form) is 
transcribed from exons 13-26 (de Souza et al., 2013; Eynon et al., 2009a). 
 
According to Jasinska and Krzyzosiak (2004), Alu sequences and repeats are the 
most frequent and simple sequence repeats, which are short segments of DNA 
interspersed throughout the genome and come in many varieties. In human ACE gene, 
the Alu insertion/deletion polymorphism can be found in intron 16, which involves 
either the presence or the absence of a 287 bp fragment. Most studies on the ancestral 
human genome in the recent history of evolutionary found that the frequency of each 
polymorphic genotype of the Alu insertion/deletion polymorphism in ACE gene 
varies across different ethnic populations. For example, one of those studies showed 
that the frequency of insertion/insertion (II), insertion/deletion (ID) and 
deletion/deletion (DD) genotypes of ACE polymorphism was 44.1%, 43.4% and 12.5% 
respectively among Caucasian Italian population (Scanavini et al., 2002). 
 
2.6.3 Ethnic variations of ACE allele distribution in difference populations and 
races  
 
It has been reported that there are inconsistent findings on the influence of ACE 
gene polymorphisms on phenotypic characteristics across different populations, due 
to the inter-ethnic variations of the ACE allele distribution (Barley et al., 1994; 
Barley et al., 1996; Mathew et al., 2001; Harrap et al., 2003; Sagnella et al., 1999). 
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Previous studies with the related data demonstrating the ethnic distribution of ACE 
ID polymorphism in different populations and races are tabulated in Table 2.1.  
 
Sagnella et al. (1999) studied the frequencies of ACE ID polymorphism among 
1577 men and women living in the South London belonging to three main ethnic 
groups: whites, people of African descent i.e. Caribbeans and West Africans and 
people of South Asian Indian origin. The study found that the distribution of the II, 
ID and DD genotypes was 18.4%, 49.6% and 32.0% respectively in whites, 18.4%, 
50.5% and 30.9% in African descent and 18.3%, 41.8% and 39.8% in those of South 
Asian origin. Among people of African descent, it was found that there were no 
statistically significant difference in the II, ID and DD genotype frequencies between 
West Africans (18.1%, 49.6% and 32.2%, respectively) and Caribbeans (20.6%, 53.7% 
and 25.7%, respectively). In another study, Mathew et al. (2001) investigated the 
distribution of the II, ID and DD genotypes among African Americans, Indians and 
whites. They reported that the II, ID and DD genotypes distribution was 11%, 60% 
and 29% in African Americans, 31%, 50% and 19% in Indians and 31%, 40% and 29% 
in whites. They also reported that there was a significant difference on the frequency 
of the deletion allele among African Americans (59%), Indians (49%) and whites 
(44%).  
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Table 2.1: Previous studies on the ethnic distribution of ACE insertion 
(I)/deletion (D) polymorphism in different populations and races 
 
Study Subjects   Population Race Sample  
size 
The distribution of ACE I/D polymorphism 
II (%) ID (%) DD (%) I allele D allele 
Schachter et al. (1994) Centenarian  French Caucasian 310 16.6 43.8 39.6 0.385 0.615 
Miller et al. (1996) Normal British Caucasian 1906 24.0 50.0 26.0 0.490 0.510 
Montgomery et al. (1998) Army UK Caucasian 78 25.6 59.0 15.4 0.551 0.449 
Montgomery et al. (1999) Army UK Caucasian 123 24.0 57.0 19.0 0.525 0.475 
Sagnella et al. (1999) Normal   Londoner 
 
Caucasian  462 18.4 49.6 32.0 0.432 0.568 
 African descent 462 18.4 50.5 30.9 0.437 0.563 
  West African 176 18.1 49.6 32.2 0.429 0.571 
  Caribbean 286 20.6 53.7 25.7 0.474 0.526 
  South Asian 
Indian origin 
442 18.3 41.8 39.8 0.392 0.608 
Alvarez et al. (2000) Athlete Spanish Caucasian 60 25.0 58.0 17.0 0.540 0.460 
Normal  Caucasian 400 16.0 45.0 39.0 0.380 0.620 
Mathew et al. (2001) Normal  American Caucasian 82 31.0 40.0 29.0 0.510 0.490 
  African 
American 
142 11.0 60.0 29.0 0.410 0.590 
  Indian 136 31.0 50.0 19.0 0.560 0.440 
Nazarov et al. (2001) Athlete Russian Caucasian 217 19.0 51.0 29.0 0.445 0.555 
Normal  Caucasian 449 23.0 52.0 24.0 0.490 0.510 
Collins et al. (2004) Athlete African South African 447 21.7 51.7 26.6 0.475 0.525 
Normal  South African 199 17.6 49.8 32.7 0.425 0.575 
Scott et al. (2005b) Athlete African Kenyan  291 15.1 51.2 33.7 0.407 0.593 
Normal  Kenyan 85 14.1 48.2 37.7 0.382 0.618 
Yang et al. (2006) Normal Chinese  Asian 221 41.0 49.4 9.6 0.654 0.346 
Patient  Asian - 38.8 42.1 19.1 0.598 0.402 
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Table 2.1: Previous studies on the ethnic distribution of ACE insertion 
(I)/deletion (D) polymorphism in different populations and races (continued) 
 
 
Study Subjects   Population Race Sample  
size 
The distribution of ACE I/D polymorphism 
II (%) ID (%) DD (%) I allele D allele 
Amir et al. (2007) Athlete  Israelite Asian 121 12.0 36.0 52.0 0.300 0.700 
Normal  Caucasian 247 10.0 46.0 43.0 0.340 0.660 
Cam et al. (2007) Normal  Turkish Caucasian 55 21.8 41.8 36.4 0.427 0.573 
Jayapalan et al. (2008) Normal  Malaysian Malay 274 51.1 39.4 9.5 0.708 0.292 
  Chinese 150 40.0 46.7 13.3 0.634 0.366 
  Indian 213 35.7 45.2 19.2 0.583 0.417 
 Berdeli and Cam (2009) Normal  Turkish Caucasian 1063 16.1 47.7 36.2 0.399 0.601 
Deeba et al. (2009) Patient  
 
South Indian Asian 185 
 
23.0 
 
45.0 
 
32.0 
 
0.460 
 
0.540 
 Normal  201 37.0 42.0 21.0 0.580 0.420 
Min et al. (2009) Athlete Japanese Asian 227 32.5 42.6 24.9 0.538 0.462 
Cieszczyk et al. (2010) Athlete Polish Caucasian 28 28.6 64.3 7.1 0.607 0.393 
Normal   115 19.2 50.4 30.4 0.443 0.557 
Jayapalan et al. (2010) Patient Malaysian South East 
Asian 
62 30.6 56.4 13.0 0.588 0.412 
  - 36.4 47.3 16.3 0.601 0.399 
Shaikh et al. (2012) Patient Pakistani Asian 464 26.1 54.2 19.7 0.535 0.465 
Normal   150 28.0 32.0 40.0 0.440 0.560 
Wang et al. (2013) Athlete European Caucasian 191 21.9 43.4 34.7 0.436 0.564 
Athlete Japanese 
and 
East Asian 362 42.3 42.2 15.5 0.634 0.366 
Taiwanese        
Normal USA  Caucasian 1248 24.1 49.3 26.6 0.488 0.512 
Normal Japanese 
and  
East Asian 1244 45.0 43.7 11.3 0.669 0.331 
  Taiwanese        
Zhou et al. (2013) Normal Chinese  Asian 260 11.9 23.1 65.0 0.235 0.765 
Patient  Asian 343 30.9 37.5 31.6 0.497 0.504 
Jastrzębski et al. (2014) Athlete Polish Caucasian 121 30.6 53.7 15.7 0.574 0.426 
Normal  Caucasian 115 19.2 50.4 30.4 0.443 0.557 
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In French centenarians, Schachter et al. (1994) observed that the frequency of II, 
ID and DD genotypes was 16.6%, 43.8% and 39.6% among 310 French centenarians. 
Besides, 1063 healthy white Western Turkish Caucasians were examined for the 
prevalence of the ACE ID polymorphism by Berdeli and Cam (2009). Their results 
showed that the ACE gene I allele frequency was 39.9% and D allele frequency was 
60.1%, and the frequency of the ACE gene II, ID and DD genotype was 16.1%, 47.7% 
and 36.2% respectively. In another study involving Turkish athletes (Caucasian), it 
was found that the frequency of II, ID and DD genotypes was 21.8%, 41.8% and 
36.4% amongst female non-elite Caucasian Turkish athletes (Cam et al., 2007). The 
distribution of II, ID and DD genotypes was 12.5%, 50% and 37.5% among 80 white 
male gymnasts from the Italian population (Morucci et al., 2014).  
 
In a study comparing Asian and Caucasian populations (Li et al., 2012), the 
authors found that the II, ID and DD genotypes distribution were 36.4%, 47.3% and 
16.3% in Asians versus 24.9%, 46.5% and 28.6% in Caucasians, nevertheless no 
significant difference in the distribution of the genotypes between Asians and 
Caucasians was observed. Regarding study on distribution of ACE ID polymorphism 
in the Malaysian population, a previous study carried out by Jayapalan et al. (2008) 
has recruited 274 Malays, 150 Chinese and 213 Indians ethnic subgroups in Malaysia. 
They found that the distribution of the II, ID and DD genotypes in the Malay 
subgroup was 51.1%, 39.4% and 9.5%, respectively. In Chinese, the distribution was 
40.0%, 46.7% and 13.3% respectively, and the distribution was 35.7%, 45.2% and 
19.2% respectively in Indian subgroup. 
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2.6.4 Association between ACE gene I/D polymorphism and human physical and 
fitness performance 
 
Genetic predisposition has great implications in the characterisation of an 
individual as a great athlete apart from the specific training and nutritional follow-up 
factors. Studies of genes that influence human physical performance show a strong 
heritability of key endurance and strength phenotypes. Endurance phenotypes 
include maximal oxygen uptake, lactate threshold and economy movement, while 
strength phenotypes consist of muscle strength and sprint performance (Ginevičienė 
et al., 2011a).  
 
It is known that the presence of the extra fragment has been found to be 
associated with lower circulating and tissue ACE activity, while the absence of the 
287 bp fragment was associated with relatively higher ACE activity (Myerson et al., 
1999). The three genotype variants exist are II, ID and DD. Even though this marker 
lies in an intronic region, it was shown to be functional and gave strong and 
consistent marker for ACE activity (Jones et al., 2002). Based on previous studies, 
the I allele has been proven to be associated with fatigue resistance in skeletal muscle 
and endurance performance, while the D allele has been associated with power or 
sprint performances (Tsianos et al., 2004; Montgomery et al., 1999). Min et al. (2009) 
found that the effects of ACE ID polymorphism on endurance- and power-oriented 
performance are more prominent in male athletes. ACE ID genotype was highly 
distributed in both short-distance and long-distance runners. Several previous studies 
with the related data demonstrating the association between ACE insertion (I) / 
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deletion (D) polymorphism and human endurance, muscular strength and power 
status in different population and races are summarized in Table 2.2. 
 
Table 2.2: Previous studies on the association between ACE insertion (I)/deletion 
(D) polymorphism and human endurance, muscular strength and power status 
in different populations and races 
 
Study Discipline 
Level of  
athletes 
Ethnicity & 
Population 
Sample 
size 
Frequency of allele/genotype and 
association of allele/genotype with 
human fitness performance 
Ash et al. 
(2011) 
Endurance 
runners, sprint 
and power 
event athletes 
National or 
international 
Ethiopian  
East African  
524 A 
317 C 
There was no association between 
ACE gene variation and elite 
endurance status amongst 
Ethiopians population.  
Cieszczyk et 
al. (2009) 
Rowers 
Olympic and 
World 
champion 
Polish 
Caucasian 
55 MA 
115 C 
The frequency of I allele in rower's 
group differed significantly from 
which in controls. 
Collins et al. 
(2004) 
Triathlons Mixed 
South 
African born 
100 
fastest 
finishers 
100 
slowest 
finishers 
166 C 
Excess of I allele in ‘fast finisher’ 
group (p = 0.036) and a linear trend 
for increasing I allele frequency 
from the controls through the slow 
finishers to the fast finishers (p = 
0.033) 
Gayagay et 
al. (1998) 
Rowers National 
Australian 
Caucasian  
 
43 MA 
21 FA 
75 MN 
39 FN 
An excess of the ACE I allele (p < 
0.02) and II genotype (p = 0.03) 
were observed in Australian 
national rowers compared to the 
normal population.  
A = athletes; C = control; FA = female athletes; MA = male athletes; FN = female non-athletes; MN = male 
non-athletes. “p” indicates statistical significant level. 
  
